Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

A Look At Neogen’s (NEOG) Valuation As Recent Share Price Move Highlights Mixed Return History

Neogen (NEOG) came into focus after a recent move in its share price, with the stock last closing at $9.53. For investors, that price helps frame the discussion around value and expectations. See our latest analysis for Neogen. That recent move sits within a mixed picture, with a strong year to date share price return of 36.14% and a 1 year total shareholder return of 68.97% contrasting with a 3 year total shareholder return of 44.46% and a 5 year total shareholder return of 79.38%. This...
NYSE:BXP
NYSE:BXPOffice REITs

Is Boston Properties (BXP) Offering Value After Recent Share Price Swings?

Wondering whether BXP at around US$59.37 is offering value or just value traps? This article breaks down what the current price might really mean for you. The stock has recently shown mixed returns, with a 2.3% gain over the last week and 14.7% over the last month, set against a year to date return of a 12.5% decline and a 1 year return of a 3.8% decline. Over the longer term, the picture is uneven, with a 37.9% gain across 3 years contrasted by a 29.0% decline over 5 years. This can leave...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

If Bitcoin And AI Both Win These Cryptocurrency Stocks Could Surprise

Crypto and blockchain are back in focus as investors look for assets that can handle higher energy costs, sticky inflation risks, and shifting central bank plans. With AI-related demand supporting parts of global trade and payment systems under pressure from geopolitical tension, the broader digital infrastructure story is still evolving. The Top Cryptocurrency and Blockchain Stocks screener cuts through the noise by highlighting companies directly linked to this theme, without relying on...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Cohu (COHU) Valuation Check After Upgraded 2026 Outlook And Strong AI And High Performance Computing Momentum

Cohu (COHU) gave investors fresh data to work with after first quarter 2026 results, combining higher semiconductor test demand tied to AI and high performance computing with updated guidance and a larger opportunity pipeline. See our latest analysis for Cohu. Those stronger AI and high performance computing headlines have arrived alongside a sharp re-rating, with an 85.25% year to date share price return and a very large 1 year total shareholder return, even after a recent 3.72% 1 day...
NasdaqGM:MAAS
NasdaqGM:MAASInsurance

Assessing Maase (MAAS) Valuation After A Sharp Multi‑Month Share Price Surge

Recent price action and business snapshot Maase (MAAS) has drawn investor attention after a 63% share price move over the past month and 58% over the past 3 months, prompting a closer look at its current fundamentals. The company provides technological intelligence and capital investment services in China through a technology-driven independent financial service platform and independent wealth management services. It reports revenue of CN¥3.483 and a net loss of CN¥1.775. See our latest...
TSX:EQX
TSX:EQXMetals and Mining

Equinox Gold (TSX:EQX) Valuation Check As Q1 Strength, Valentine Ramp Up And New Dividend Draw Attention

Equinox Gold (TSX:EQX) is back in focus after strong Q1 production, a successful Valentine mine ramp up, significant debt reduction, and a new dividend, all announced ahead of its May 6 financial results. See our latest analysis for Equinox Gold. Despite a recent 6.4% 30 day share price decline and a 7.6% 90 day share price pullback to around CA$19.03, the 1 year total shareholder return of 111.4% and 3 year total shareholder return of about 1.5x suggest momentum has been strong. Recent Q1...
AIM:AOM
AIM:AOMSoftware

ActiveOps Leads Our Top 3 UK Penny Stock Selections

The UK market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, highlighting the interconnectedness of global economies. In such fluctuating conditions, investors often look beyond well-known names to explore opportunities in lesser-known stocks. Penny stocks—typically smaller or newer companies—remain a relevant area for investment as they can offer unique value and growth prospects when supported by strong financials.
TSE:9021
TSE:9021Transportation

West Japan Railway (TSE:9021) Valuation Check After Strong FY 2026 Sales And Earnings

Full year 2026 results set the tone for West Japan Railway West Japan Railway (TSE:9021) has drawn fresh attention after reporting full year results to March 31, 2026, with sales of ¥1,845,840 million and net income of ¥127,499 million. Basic earnings per share from continuing operations came in at ¥277.73. Investors now have a new reference point ahead of the company’s 2026 earnings call scheduled for May 1. See our latest analysis for West Japan Railway. At a share price of ¥2,857.0, West...
ASX:GYG
ASX:GYGHospitality

Assessing Guzman Y Gomez’s Valuation As The Brekkie Burrito Challenge Lifts Interest In GYG (ASX:GYG)

Guzman y Gomez (ASX:GYG) has drawn fresh attention from investors after launching its “Brekkie Burrito Challenge” across Chicagoland, a month long promotion focused on customizable breakfast burritos, value pricing and a satisfaction guarantee. See our latest analysis for Guzman y Gomez. At a share price of A$19.24, Guzman y Gomez has a 30 day share price return of 26.58%, yet its year to date share price return of a 10.84% decline and 1 year total shareholder return of a 39.19% decline...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

A Look At BeOne Medicines (ONC) Valuation After FDA Priority Review And New HH160 Collaboration

BeOne Medicines (ONC) has drawn fresh attention after the FDA granted Priority Review to a supplemental Biologics License Application for TEVIMBRA with ZIIHERA and chemotherapy in advanced HER2-positive gastroesophageal cancers, alongside a global HH160 collaboration. See our latest analysis for BeOne Medicines. Despite the FDA Priority Review for TEVIMBRA and the new HH160 collaboration, the share price return has softened recently. The 30-day share price return is 5.45% and the 90-day share...
CPSE:RBREW
CPSE:RBREWBeverage

Royal Unibrew (CPSE:RBREW) Valuation After PepsiCo License Expiry Plans And Shift Toward Own Brands

Royal Unibrew (CPSE:RBREW) is back in focus after disclosing that its PepsiCo license agreements for Denmark, Finland, and the Baltic states, currently about 13% of net revenue, will expire at the end of 2028. See our latest analysis for Royal Unibrew. Despite the PepsiCo update and a series of recent announcements, including a larger share buyback, AGM approvals and Q1 2026 results, the stock has had a 30 day share price return of a 19.7% decline and a 1 year total shareholder return of a...
CPSE:ZEAL
CPSE:ZEALBiotechs

Zealand Pharma Obesity Pipeline Progress Brings New Catalysts And Partner Upside

Zealand Pharma and Roche have advanced obesity candidate petrelintide into Phase 3 development. Boehringer Ingelheim reported positive Phase III results for obesity drug survodutide, co-invented with Zealand Pharma. Zealand Pharma is eligible for milestone payments and royalties from survodutide, subject to future sales. CPSE:ZEAL is trading at DKK309.0, with the stock down 32.8% year to date and 36.4% over the past 12 months, alongside gains of 39.1% over three years and 57.4% over five...
NYSE:R
NYSE:RTransportation

How Ryder’s Dividend Hike, Buyback Plan, and Higher 2026 EPS Guidance Will Impact Ryder System (R) Investors

Ryder System’s board recently declared a regular quarterly cash dividend of US$0.91 per share to be paid on June 19, 2026, and authorized a new share repurchase plan of up to 2.0 million shares running through May 1, 2028. These moves, alongside first-quarter earnings that prompted higher full-year 2026 EPS guidance, underline management’s emphasis on disciplined capital deployment and shareholder returns supported by a largely contract-based business model. With Ryder increasing its 2026...
TSX:GFL
TSX:GFLCommercial Services

Assessing GFL Environmental (TSX:GFL) Valuation After Raised 2026 Guidance And Acquisition Progress

Raised 2026 guidance puts acquisitions in focus GFL Environmental (TSX:GFL) lifted its full year 2026 revenue outlook after reporting record first quarter adjusted EBITDA margins and better than expected revenue, tying the upgrade directly to eight acquisitions completed so far. The company now expects 2026 revenue of about CA$7.32b to CA$7.34b, an increase of roughly CA$320 million to CA$340 million versus its original February guidance, reflecting added scale from recent deals. See our...